×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SESSION 4: CAUSALITY ASSESSMENT OF DILI
Session Chair(s)
Gaby L. Danan, MD, PhD
Pharmacovigilance Expert
GLD, France
- Causality assessment criteria
- Methods, with focus on ‘RUCAM’
- Exercises
Speaker(s)
CAUSALITY ASSESSMENT OF DILI
Gaby L. Danan, MD, PhD
GLD, France
Pharmacovigilance Expert
Have an account?